Skip to main content

Advertisement

Log in

Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

To investigate the possible involvement of the butyrylcholinesterase (BCHE) K variant and transferrin (TF) C2 variant in the manifestation of Alzheimer's disease (AD), we analyzed the BCHE, TF and apolipoprotein E (APOE) genotypes of 164 sporadic AD patients and 239 normal elderly controls.

The frequencies of the BCHE K and TF C2 did not differ between the AD patients and controls (P > 0.1). The occurrence of the APOE ε4 did not influence the distribution of the BCHE K and TF C2 variants (P > 0.1). No linkage disequilibrium between the BCHE K and TF C2 was observed either in both the AD patients and controls (P > 0.1).

In conclusion, neither the BCHE K nor the TF C2 confers a risk for AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received February 9, 2001; accepted June 8, 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, K., Jhoo, J., Lee, J. et al. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans. J Neural Transm 108, 1159–1166 (2001). https://doi.org/10.1007/s007020170005

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007020170005

Navigation